title: Antiretroviral rounds. Too many options?
abstract: We asked three experts which antiretroviral regimen they would recommend next for a patient with triple-class resistance and low viremia--and got three different answers.
authors.forename: Sharon
authors.initials: S
authors.lastname: Walmsley
authors.forename: Timothy
authors.initials: T
authors.lastname: Wilkin
authors.forename: Graeme
authors.initials: G
authors.lastname: Moyle
mesh_terms: D018791:CD4 Lymphocyte Count; D005838:Genotype; D006678:HIV / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000145:classification / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000145:classification / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors